|
Jan 17
|
Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug
|
|
Jan 12
|
Here's Why Evogene (EVGN) is a Great Momentum Stock to Buy
|
|
Dec 21
|
Biomica CEO Set to Attend JP Morgan Healthcare Week in San Francisco, January 8-11, 2024
|
|
Dec 19
|
Casterra Appoints New CEO and Expands Team to Drive Growth and Innovation
|
|
Dec 5
|
Is Compugen (CGEN) Outperforming Other Medical Stocks This Year?
|
|
Dec 5
|
Lavie Bio Announces a Distribution Agreement with WinField United Canada for its Bio-Inoculant Seed Treatment Yalos™
|
|
Nov 29
|
Bears are Losing Control Over Evogene (EVGN), Here's Why It's a 'Buy' Now
|
|
Nov 28
|
Lavie Bio Announces Expansion of its Bio-Inoculant Product for Spring Wheat, Yalos™, to Durum and Barley
|
|
Nov 8
|
Lavie Bio Reports Advancement in Bio-Fungicide Program Against Downy Mildew with 2023 Field Trial Results
|
|
Nov 2
|
Evogene Schedules Third Quarter 2023 Financial Results Release & Conference Call for November 15, 2023
|
|
Oct 31
|
Colors Farm, Evogene and Ben-Gurion University Collaborate to Establish Crustacean Gene Editing Technology
|